论文部分内容阅读
Purpose: Postoperative non-small cell lung cancer (NSCLC) patients require adjuvant therapy to improve their prognosis.In this study, we investigated the efficacy of a sequential combination of cellular immunotherapy (CIT) and chemotherapy for postoperative NSCLC.